图书简介

Chapter 1: Radical prostatectomy versus observation for localized prostate cancer: The European Randomized Study of Screening for Prostate Cancer (ERSPC); Chapter 2: The Influence of Finasteride on the Development of Prostate Cancer: Prostate Cancer Prevention Trial (PCPT)1; Chapter 3: MRI-Targeted or Standard Biopsy for Prostate Cancer Diagnosis: The PRECISION Trial; Chapter 4: Long-term survival among men with conservatively treated localized prostate cancer: Conservative management of prostate cancer-watchful waiting; Chapter 5: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer; Chapter 6: Radical prostatectomy versus Observation in Early Prostate Cancer: Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4); Chapter 7: Radical prostatectomy versus observation for localized prostate cancer: The PIVOT Trial; Chapter 8: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy: The Prostate Testing for Cancer and Treatment (ProtecT) trial; Chapter 9: Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy; Chapter 10: Quality of life and satisfaction with outcome among prostate-cancer survivors: Quality of life after primary treatment of localized prostate cancer; Chapter 11: Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial: The Southwest Oncology Group 8794 Trial; Chapter 12: Survival Following Primary Androgen Deprivation Therapy Among Men with Localized Prostate Cancer; Chapter 13: Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer; Chapter 14: Intermittent versus Continuous Androgen Deprivation in Prostate Cancer: Intermittent androgen deprivation therapy (SWOG Trial 9346); Chapter 15: Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer: The TAX 327 Trial; Chapter 16: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer; Chapter 17: Abiraterone and Increased Survival in Metastatic Prostate Cancer; Chapter 18: Enzalutamide in Metastatic Prostate Cancer before Chemotherapy: The PREVAIL Study; Chapter 19: The EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma; Chapter 20: Nephrectomy Followed by Interferon Alfa-2b Compared With Interferon Alfa-2b Alone For Metastatic Renal-Cell Cancer; Chapter 21: Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma; Chapter 22: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma: CheckMate 025; Chapter 23: The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer: A Further Report with 7 Years of Follow-Up; Chapter 24: Bacillus Calmette-Guerin (BCG) Immunotherapy for Recurrent Non-Invasive Transitional Cell Carcinoma of the Bladder: A Randomized Southwest Oncology Group Study; Chapter 25: Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer; Chapter 26: Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer; Chapter 27: A Randomized Comparison of Cisplatin Alone or in Combination with Methotrexate, Vinblastine, and Doxorubicin in Patients with Metastatic Urothelial Carcinoma: A Cooperative Group Study; Chapter 28: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study; Chapter 29: Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma: KEYNOTE-045; Chapter 30: Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer; Chapter 31: Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide: PVB versus BEP; Chapter 32: Urinary Volume, Water and Stones Recurrence in Idiopathic Calcium Nephrolithiasis: a 5-Year Randomized Prospective Study; Chapter 33: A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones; Chapter 34: First Clinical Experience with Extracorporeally Induced Destruction of Kidney Stones by Shock Waves; Chapter 35: Shockwave lithotripsy versus ureteroscopy for lower pole caliceal calculi 1 cm or less; Chapter 36: Extracorporeal shockwave lithotripsy versus percutaneous nephrolithotomy for lower pole nephrolithiasis: The Lower Pole I Study; Chapter 37: Medical Expulsive Therapy in Adults with Ureteric Colic: The SUSPEND Trial; Chapter 38: Burch Colposuspension versus Fascial Sling to Reduce Urinary Stress Incontinence: The Stress Incontinence Surgical Treatment Efficacy (SISTEr) Trial; Chapter 39: Retropubic versus Transobturator Midurethral Slings for Stress Incontinence: The Trial of Mid Urethral Slings (TOMUS); Chapter 40: A midurethral sling to reduce incontinence after vaginal prolapse repair: The Outcomes Following Vaginal Prolapse Repair and Midurethral Sling (OPUS) trial; Chapter 41: A Randomized Trial of Urodynamic Testing Before Stress Incontinence Surgery: The VALUE Study; Chapter 42: Anticholinergic Therapy versus Onabotulinumtoxin A for Urgency Urinary Incontinence: The Anticholinergic versus Botulinum Toxin Comparison-ABC-study; Chapter 43: Oral sildenafil in the treatment of erectile dysfunction; Chapter 44: Treatment of men with erectile dysfunction with transurethral alprostadil; Chapter 45: Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux: Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial; Chapter 46: A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia: The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate; Chapter 47: The Efficacy of Terazosin, Finasteride, or both in Benign Prostatic Hyperplasia: The Veterans Affairs Cooperative Benign Prostatic Hyperplasia Study; Chapter 48: Chlorhexidine-Alcohol versus Povidone- Iodine for Surgical-Site Antisepsis; Chapter 49: Clean, Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease; Chapter 50: The Surgical Learning Curve for Prostate Cancer Control after Radical Prostatectomy

Trade Policy 买家须知